TI
BSTC

Trexquant Investment’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Trexquant Investment’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,524
Closed -$326K – 1500
2017
Q4 		$326K Buy
+7,524
New +$338K 0.04% 713
2016
Q2 		– Sell
-8,950
Closed -$312K – 1207
2016
Q1 		$312K Buy
+8,950
New +$328K 0.04% 723

Other funds holding BSTC

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Trexquant Investment's BSTC Position: Q1 2018 in Review

Trexquant Investment sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 7,524 shares — an estimated $326K sold.

Trexquant Investment first reported a position in BSTC in Q1 2016 and held it in 2 quarters. The position peaked at $326K in Q4 2017. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

  • Trexquant Investment reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
  • Trexquant Investment sold 7,524 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $326K.
  • Trexquant Investment first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 2 quarters.
  • Trexquant Investment's BioSpecifics Technologies Corp. position peaked at $326K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.